US2602042A - Processing methyl cellulose and the products thereof - Google Patents

Processing methyl cellulose and the products thereof Download PDF

Info

Publication number
US2602042A
US2602042A US769071A US76907147A US2602042A US 2602042 A US2602042 A US 2602042A US 769071 A US769071 A US 769071A US 76907147 A US76907147 A US 76907147A US 2602042 A US2602042 A US 2602042A
Authority
US
United States
Prior art keywords
methylcellulose
chloroform
added
treating solution
swelling agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US769071A
Inventor
Charles W Abbott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US769071A priority Critical patent/US2602042A/en
Application granted granted Critical
Publication of US2602042A publication Critical patent/US2602042A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00Preparation of cellulose ethers
    • C08B11/20Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives

Definitions

  • My invention relates to a process of treating methylcellulose and the products thereof.
  • my invention includes the dispersing or dividing of methylcellulose.
  • Methylcellulose disperses very slowly in a liquid, and in accordance with prior art practices, the residue becomes a tough, membranous mass upon evaporation of the liquid used during disper- S1011.
  • methylcellulose treated in accordance with my process has a greater capacity for absorbing liquids and at the same time has a more rapid rate of absorption than methylcellulose in the state or condition heretofore available.
  • methylcellulose treated in accordance with my invention Another particular characteristic of methylcellulose treated in accordance with my invention is that it' rapidly combines with liquids to form a gel, which liquids include :body fluids and body exudates.
  • This particular characteristic of the product of my process makes the product especially useful in medical dressings.
  • These medical dressings may include other carrier means or the methylcellulose may function as the surgical dressing.
  • One of the forms of surgical dressings made in accordance with my invention is a powdery or fiber-like material which may be applied directly to burns or wounds in first aid or in subsequent treatment thereof. Another form thereof is where such product is incorporated in a dressing. or used to absorb drainage. For example, it may be employed in connection with a tapped, infected lung, osteomyelitis and other types of infection where we have a leakage of body fluids which are desired to be absorbed.
  • eschar In the prior art treatment of burns, tissues form on the surface and are known as an eschar. This eschar is a layer of consolidated body exudates and dead tissue. Often under the eschar, bacteria develop and are protected before detection thereof, and before proper medicaments are disposed in reacting relation therewith.
  • One of the objects of this invention is to provide a medicated methylcellulose dressing made in accordance with my invention and which will function to supplant or take the place of the eschar and will further function to absorb the body exudates and thus permit the body tissues to heal in the absence of a true eschar.
  • a solution of tannic acid or asolution of silver nitrate is applied, or they areconsecutively applied.
  • a tough, leathery-dike coating or eschar develops and often bacteria develop under the surface of this eschar.
  • products of my invention comprise included medicaments disposed to readily react with injured tissues. Thus, I am able to obtain not only the effect of the medicaments, but to provide an exeluding layer which assists in preventing bacterial development.
  • the product of my invention is substantially inert to usual medicaments and body fluids, and thus is not conducive to complications or reactions, and has the physical characteristic of bringing about absorption of body exudates and providing a protective envelope.
  • the product of my invention is not only inert, non-toxic, and non-irritating to burns, Wounds or body tissues but has other desired properties. These include absorption properties, ability to hold medicaments in a Well divided state and to effectively release the medicamcnts upon wetting of the product, ability to gel, and to form a protective envelope.
  • Methylcellulose is readily obtained commercially and is generally sold in types having difierent viscosities.
  • Dow Chemical Company sells methylcellulose under the trade name of Methocel and it is available on the market in several viscosities or types, as: 12, 25, 100, 400, 1560 and 4000 centipoises.
  • the literature of Dow Chemical Company states that Methocel is synthesized from highly purified cellulose by interaction with caustic soda and methyl chloride, and that Methocel pharmaceutical grade is neutral, odorless, tasteless and completely inert. In my invention, I may use methylcellulose regardless of its viscosity in appropriate formulas.
  • I'firs't subject methylcellulose to what I will term a primary treating solution, or an organic dispersing agent.
  • This solution functions as a dispersing and probably as a swelling agent and opens up or divides the methylcellulose, or the fibers or fibrils thereof.
  • I employ pharmaceutical grade methylcellulose either as obtained on the market or after the same has been mechanically sub-divided as by treatment in a hammer mill.
  • the said primary treating solutions comprise chloroform, methylene chloride, ethyl acetate, methyl acetate, methyl lactate, ethyl lactate, lactic acid, or a combination of such agents.
  • a small quantity of water as apparently water present in small quantities aids in the primary treatment.
  • I have found that where I treat methylcellulose with such a primary treating solution, there is swelling, dividing or opening up of the methylcellulose, or the fibers or fibrils thereof.
  • methylcellulose is subjected to the action of my primary treating solution and then the volatiles are evaporated, I find that the residue is a harsh, tough and membranous mass, and is no more suited to the objects of my invention than the original methylcellulose.
  • the step of expanding the methylcellulose, or the fibers or fibrils thereof is followed by a second step or treatment with what I term a secondary treating solution, or an organic dispersing agent, to retain the methylcellulose, or the fibers or fibrils thereof in a divided or opened state.
  • the secondary treating solution, or organic dispersing agent must be miscible to the primary treating solution.
  • Some of the agents employed in this secondary step include fractional distillates of petroleum. The boiling point thereof must be higher than the boiling point of the primary treating solution. Thus, fractional petroleum distillates having a boiling point in the range of 40 C. to 180 C., will be within the range of my invention as secondary treating solutions and the particular one selected in a given case must be selected in accordance with the boiling point of the primary treating solution.
  • Other secondary treating solutions which I have employed include coal tar distillates comprising benzene, toluene, and dimethyl benzene.
  • I disperse the methylcellulose in the primary treating solution and cause a dividing or opening up of the methylcellulose, or its fibers or fibrils. Then in the presence of a secondary treating solution having a boiling point of approximately 15 above the boiling point of the primary treating solution, I remove the primary treating solution and then finally recover the divided methylcellulose from the secondary treating solution.
  • a secondary treating solution having a boiling point of approximately 15 above the boiling point of the primary treating solution.
  • I remove the primary treating solution and then finally recover the divided methylcellulose from the secondary treating solution.
  • One way of expressing the matter is that I have discovered that I can recover the divided methylcellulose when substantially in the presence of a secondary treating solution without causing the methylcellulose to coalesce into a tough, membranous mass. When 'an attempt was made to recover the divided methylcellulose from the primary treating solution, it was found that the residue was a tough membranous mass.
  • medicaments to the divided methylcellulose of this invention is to add the medicaments when the primary and secondary treating solutions are present.
  • the methylcellulose is in the presence of the primary and secondary treating solutions, it has reached substantially its greatest state of dispersion and obviously at such time better dispersion of the medicaments will obtain,
  • the medicaments to' be added must be at least dispersible in the treating solutions and thus the treating solutions function to provide more complete dispersionv of the medicaments in the methylcellulose.
  • the medicaments which can be incorporated inthe divided methylcellulose .of my invention when both the primary and secondary treating solutions are present, will of coursebe those which are not adversely afiected by such treating solutions. Due to the nature of the primary and secondary treating solutions, they will not form any substantial limiting factor as to the medicaments which may be employed. They are very stable chemical compounds and have little or no reaction with medicaments commonly employed in medical dressings. Of course, the medicaments commonly employed should be those which can be dissolved or at least dispersed in treating solutions to obtain the desired dispersion in the end product. Thus the medicaments should be added at least at no later stage than when some of the secondary treating solution is present and preferably when both treating solutions are present. While the medicaments can be added to the end product, this is not preferable as the dispersion thereof will not be as complete.
  • I include a surface active agent, of either the cation or anionactive class, in products embodying my invention which are designed for medical uses as such agents augment the wetting action of the compounds by either water or body exudates.
  • a typical agent is dioctyl sodium sulfa succinate, commonly sold as "OT 100.
  • Typical medicaments which may be added to the divided methylcellulose of my invention and their properties therein comprise: glycerol, it is hygroscopic, it is a plasticizer forming a tougher and softer protective coating, it is a dispersing agent for many medicaments, and is anti-bacterial; polyethylene glycol, it is soluble in both oil and water and functions as a dispersing agent for other medicaments; boric acid; sulfa compounds, as sulfanilamide, sulfathiazole, sulfapyridine, etc.; merthiolate; mercurochrome; hexylresorcinol; dyes, as azo dyes, acridine dyes, fluorescein dyes, rosiniline dyes, phenolphthalein dyes, and miscellaneous dyes; local and topical anaesthetics; digestants, as pancreatin, pepsin, bromelin and papain; antibiotic substances, as penicillin and salts
  • Example 1 Methylcellulose, 4000 centipoises gms 2.5 Activated charcoal gm .1 Chloroform c. c 40 Petroleum distillate, B. P. 77 C. to 110 C.
  • activated charcoal was employed and its chief characteristic was that of absorbing odors.
  • the mixture was heated. ten minutes at 130C.
  • the chloroform, due'toitslower boiling point, was first driven off and finally the petroleum distillate was driven off.
  • the residue remaining was in the nature of a soft felt-like pad. It was used as a surface coating on a gauze bandage and the gauze side of the bandage was placed in closed proximity to the wound of an ulcer case.
  • the product readily gelled on the surface of the gauze bandage and functioned as a carrier for the charcoal, and in turn the charcoal tended to absorb body odors.
  • centipoise of the methylcellulose employed will be abbreviated to c. p, Also, the details of the action of the primary treating solution and the secondary treating solution will be somewhat abbreviated but the nature of each will be generally indicated. Also, the petroleum distillate which was used in the following examples had a boiling point of 77 C. to 110 C. unless otherwise indicated.
  • the chloroform was used as the primary treating solution and the methylcellulose and ethyl cellulose solution was placed therein.
  • the said agents were allowed to remain in contact for about thirty minutes and with agitation and the dispersion appeared complete.
  • Thepetroleum distillate was added as the secondary treating solution.
  • the dispersion was filtered and the treating solutions were partly removed by filtration. Then after air drying and finally by heating for ten minutes at a temperature of C. to remove traces of petroleum distillate, a final product was obtained which was a compact and coherent pad. It was not too friable and was slow to absorb water. It was a useful product but not a preferred form.
  • the ethyl cellulose functioned as a binder to hold the end product in a form retaining pad.
  • the chloroform was employed as the primary treating solution and the methylcellulose and ethyl cellulose solution were placed therein.
  • the activated charcoal was added and well dispersed.
  • Petroleum distillate was added as the secondary treating solution.
  • the material was removed to a form and air dried and then heated to 100 C. to remove traces of the petroleum distillate. This material formed a compact pad which did not absorb water readily but which, because of the presence of activated charcoal, readily absorbed noxious odors from putrescent wounds.
  • Example 4 Methylcellulose, 4000 cp gms 30 Glycerol gms 3 OT 100 gms .3 Chloroform c. c 480 Petroleum distillate c. c 360 which were rather slow to absorb water.
  • the OT 100 had been previously dissolved in the chloroform.
  • the petroleum distillate was used as the secondary treating solution.
  • the mixture was poured into a form and partly dried by filtration and then dried by applying heat at 100 C. This material formed pads or dressings Their texture was not as soft or fluffy as other examples of my invention.
  • Chloroform in which the OT 100 had been dissolved was used as the primary treating solution and the methylcellulose was placed therein.
  • the boric acid was triturated with the glycerol and added to the above mixture.
  • Petroleum distillate was used as the secondary treating solution.
  • the mixture was poured out in forms and a portion of the treating solutions were removed by filtration.
  • the material was then divided and one portion permitted to air dry to complete removal of the treatingsolutions.
  • the second portion was dried at a temperature of 90 C. No difference was noted in the final resulting material.
  • the material was readily teased apart by means of a wool card. This final material was a fine powdery fiuif. It wet slowly with water.
  • the chloroform in which had been previously dissolved the OT 100, was used as the primary treating solution.
  • the boric acid was triturated in the glycerol and the mixture added to the dispersed methylcellulose in the chloroform.
  • the petroleum distillate which was used as the secondary treating solution, was added and the mass thoroughly mixed by stirring. The mixture was subjected to the heat of boiling water and a vacuum applied. The treating solutions were recovered, fractionated and reused. The final traces of the treating solutions were removed by subjecting the resulting material to a heat of 95 C. After a complete drying, the material was teased apart by means of wool cards. The material was a soft, fluffy mass. This material was divided into ten gram portions which were enclosed in gauze to form a medicaldressing. The material was readily wet by water. A clinical test was made and the attending nurse reported that said dressings were: Two or three times as effective as ordinary dressings in absorbing body exudates in a case of empyema.
  • the volatile solvents were recovered, fractionated and reused.
  • the mass was treated with a heat of C. to remove final traces of treating solutions.
  • the mass was then teased apart by means of wool cards.
  • the resultin material was a soft fiuify mass which was readily soluble in water.
  • the secondary treating solution petroleum distillate, was added and the whole thoroughly mixed. The treatment by vacuum and heat was followed. The material was teased to a soft fluff. The material was soluble with clifiiculty in water due to the presence of chlorophyll.
  • Example 11 ethylene glycol was substituted for glycerol.
  • Example 12 Methylcellulose; 25 op gms 10 Pancreatin mm 1.5 Sodium bicarbonate gms 6 Polyethylene glycol, M.- W. 1500 gms OT 100 gms .2 Chloroform c. c 250 Petroleum distillate c. c 250 Chloroform, in which had been dissolved the CT 100, was used as the primary treating solution.
  • the pancreatin and sodium bicarbonate was triturated with the polyethylene glycol (acting as a dispersing agent for the medicaments) until a uniform mixture was prepared.
  • the polyethylene glycol-pancreatin-sodium bicarbonate mixture was added and was readily and uniformly dispersed.
  • the secondary treating solution, petroleum distillate was next added and thoroughly dispersed. The removal by vacuum and heat was followed. . The resulting material was teased apart with wool cards to a powdery fluffy mass. It was quickly and readily soluble in water.
  • Example 13 Methylcellulose, 25 cp gms Chlorophyll (water soluble) gms .9 OT 100 gms .3 Polyethylene glycol, M. W. 1500 gms 5 Petroleum distillate c. c.. 250 Chloroform c. c 250 The chloroform, in which had been dissolved the OT 100, was used as the primary treating solution- The ylcellulose was immersed in the chloroform and the mixture was shaken until of. chlorophyll-polyethylene glycol was addedto the methylcellulose in the 'chloroformand the mixture was stirred until dispersion appeared uniform. The chlorophyll was easily dispersed by this treatment.
  • Petroleum distillate was added as the secondary treating solution and was uniformly dispersed by shaking.
  • the treating solutions were removed by vacuum and heat treatment.
  • the remaining material was readily fluffed by the use of wool cards to a fibrous powdery mass.
  • the material dissolved to a gel at a very rapid rate. This result is in contrast to the Example 9 where it was discovered that chlorophyll increased surface tension and delayed dispersion.
  • the only changes (over Example 9) were the use of methylcellulose 25 cp., polyethylene glycol M. W. 1500, and an increased amount of CT 100. This material may be used, as an example, as a dressing for chronic, necrotic ulcers.
  • the allantoin and glycerol were triturated in the polyethylene glycol until a uniform mixture was obtained and the mixture was then added to the methylcellulose which had been dispersed in chloroform.
  • the materials were intimately mixed or dispersed by stirring.
  • the petroleum distillate was added as the secondary treating solution and was dispersed by shaking.
  • the volatile solutions were removed by vacuum-heating treatment.
  • the material was easily teased to a fiuffy material by carding.
  • the medicated material was readily soluble in water.
  • This material when applied with a little water to cuts, wounds, abrasions and burns forms a neat, compact, synthetic protective coating due to the presence of methylcellulose. Also the allantoin provides conditions augmenting healing. Small cuts inflicted during shaving stopped bleeding almost instantly and were healed in twenty-four hours and they were not re-opened on shaving the second day.
  • the chloroform in which the OT 100 had been dissolved, was used as the primary treating solution.
  • the methylcellulose was immersed in this primary treating solution and was shaken for about thirty minutes and dispersion seemed complete.
  • the glycerol and allantoin were triturated into the polyethylene glycol until a uniform mixture was prepared.
  • This mixture was incorporated in the methylcellulose-chloroform mixture by stirring until uniformly dispersed.
  • the tyrothricin (in alcohol) was added to the mixture and dispersed by shaking and stirring.
  • the petroleum distillate was added and dispersed by shaking for about ten minutes and a uniform mixture was obtained.
  • the volatiles were removed by vacuum-heat treatment.
  • the material was flufied to a finely fibrous mass.
  • the wound may be moistened with a drop of water, if not already moist. A small portion of the material is placed on the surface of the wound and a few drops of water may be added if needed. A gel is formed and should be spread to provide appropriate coverage. The protective layer is permitted to dry and forms a seal over the wound. If there be need, an oiled dressing may be placed over the protective layer to prevent sticking to clothing, etc.
  • This dressing has been proven to be very effective in cases of boils. Infection has been rapidly reduced with rapid healing. In the case of an infected abrasion a protective layer of the material was applied as has been indicated. The infection subsided rapidly and healing was prompt.
  • the material has also been proven effective in cases of burns. Infection is reduced and healing progresses without a scab. The surface of the tissues may be seen through the dressing.
  • the foregoing examples illustrate some of the medicaments which can be incorporated into the products embodying my invention. Furthermore, they illustrate the use of chloroform as a primary treating solution and petroleum distillate as a secondary treating solution. In some of the examples, glycerol and/or polyethylene glycol has been employed. Also, they indicate a differential in boiling points between the primary treating solution or solutions and the secondary treating solution or solutions which will be in the neighborhood of C. and specifically 158 C.
  • the methyl acetate was added to the methylcellulose and allowed to stand for one hour.
  • Methyl acetate functioned as a primary treating solution. Then the benzene was added and the material was allowed to stand for another hour. The volatiles wereremoved by heat and the end product was soft and fluffy. In this particular example and others following, no medicaments were used as a determination wa being made. for treating solutions. As the previous examples indicated that the end product was inert to the various medicaments to be added, thus I was determining agents and formulations to obtain the proper physical characteristics of the end product.
  • Example 17 Methylcellulose, 4000 cp gms 0.5 Chloroform c. c 30 Toluene c.c 30
  • Example 18 Methylcellulose, 4000 cp gms 0.5 Chloroform c.c 30 Benzene c. c 30
  • the chloroform was added to the methylcellu lose and permitted to stand forty-four hours.
  • the benzene was added and the mass was permitted to stand five hours.
  • the volatiles were evaporated and the residue was a short felt and not fiuffy. Upon carding the material was fluffy but there were traces of lumps.
  • This example indicates that benzene can be used in my invention as a secondary treating solution.
  • the differential in boiling points between chloroform and benzene is approximately 8 C. I thus established that with as little as 8 C. between the boiling points I could first remove, dur ing evaporation, the primary treating solution and have the final recovery in the presence of the secondary treating solution.
  • Example 22 Methylcellulose, 4000 cp gms 0.5 Methylene chloride c.c- 15 Chloroform c.c 15 Petroleum solvent c.c 30
  • Toluene c. c 30 Methylene chloride and chloroform were added to methylcellulose and let stand one hour. Then added the toluene and let stand one hour. Evaporated the volatiles and the material could be readily fluffed by cards.
  • Example 26 Methylcellulose, 4000 cp gms 0.5 Chloroform c.c 20 Petroleum distillate c.c 30 Water -P c.c 1 OT gms .02
  • the methylcellulose and the OT 100 were placed'in a mortar and some of the chloroform was added. The mass was triturated and the balance of the chloroform was added periodically in small amounts. Then the mass was transferred to a cylinder and the petroleum distillate added and the mass well shaken. Upon evaporation of the volatiles, the residue was a soft, short fiber felt. It carded well. From this example and other similar examples it was determined that trituration before adding the secondary treating solution was helpfuL- Itappeared unsatisfactory to triturate after the secondary treating solution had been added but shaking whilethe secondary treating solutions are present proved helpful. Water again appeared helpful when added to the primary treating solution.
  • Example 27 A series of tests were run employing 0.5 gm. of methylcellulose; 0.02 gm.-of OT 100; 1 c. c. of water and 20 c. c. of chloroform.
  • the amount of petroleum solvent was varied and thus it was found that the lower limit of the petroleum distillate in this combination was approximately 10 c. c. and that optimum results obtained by the use of 15 c. c. or over. Also it was found that by keeping the other factors constant except the water, the maximum amount of water which can be incorporated for optimum results was 1 c. c. Un der such circumstances the amount of methylcellulose was 0.5 gm.; OT 100 was .02 gm.; chloroform was 20 c. 0.; and petroleum distillate was 30 c. c.
  • Example 28 In order to determine the range of the fraction of petroleum distillate which could be used and to determine whether methylcellulose of different viscosities could be employed, petroleum distillate having a boiling point in the range of 36 C. to 60 C. was employed and methylcellulose having a viscosity of 25 cp. was employed in this example. In the previously mentioned examples where petroleumdistillate was used, its boiling point was 77 C. to C. so as not to introduce a variable in this respect, as other factors were being determined.
  • Methylcellulose 25 cp gm 0.5 Methylene chloride c. c 30 Petroleum distillate, B. P. 30 C. to
  • the methylene chloride was added to the methylcellulose and shook for thirty minutes with balls present to aid in the agitation. Then the petroleum distillate was added and was shaken for fifteen minutes and then let stand one hour. After evaporation of the volatiles, the residue was soft and fluffy and did not need carding, but does card well.
  • the methylene chloride has a boiling point of 40 C. and the final boiling point of the fraction of petroleum distillate employed was sufiic'ientig: higher so that the final recovery of the'residue was in the presence of the petroleum distillate.
  • Example 32 Placed the methylcellulose and CT in a mortar and added thereto the primary treating solutions which consisted of methyl lactate, water and chloroform.
  • the methyl lactate was added first and the water next. This was insufiicient to completely wet the mass because of the tendency of the methylcellulose to gel and prevent wetting.
  • One 0. c. of chloroform was added and permitted to stand for a few minutes until the mass was wet. The mass was triturated and 9c. 0. of chloroform was added in 1 c. c. portions with trituration after each addition. In each case a stiff paste formed.
  • 15 c. c. of chloroform was added in 5 c. c. portions with trituration after each addition. A white, milky suspension was formed.
  • the volatiles were removed by evaporation with heat.
  • the residue comprised a friable mass which was somewhat more compact than the residue obtained from methylcellulose op. 25. Trituration was required to pulverize the residue to a powder.
  • the powder was of substantially the same quality as obtained from methylcellulose op. 25. It wet easily. 1
  • Example 32 An examination under the microscope revealed substantially the same structure as obtained in Example 32. A few ball like portions were found. These had a circular edge with a light portion surrounding a dark center. For the most part the material consisted of pitted irregular masses. The later picture was seen under 550 magnifications and the former under 110 magnifications. No fibrous fragments were found.
  • Examples 32 and 33 thus indicated that methyl lactate can be employed in my invention and with satisfactory results. Again it appeared that the methylcellulose employed need not have any Example 34 Methylcellulcse, 25 .cp gms 0.5000 Water c. c 1 Latic acid gms 1 OT 100 ems .02 Chloroform c. c 25 Petroleum distillate, B. P. 120 C.- to
  • the water, lactic acid and chloroform were used as the primary treating solution.
  • the methylcellulose was placed in a mortar and to it were added the water, OT 100 and lactic acid and also 5 c. c. of chloroform. (The chloroform was added at this time because the water and lactic acid were not enough to 18 wet the methylcellulose.) triturated to a stiff paste. Then the chloroform was added in 5 c. c quantities with trituration after'eachaddition. A milky suspension was formed.
  • the petroleum solvent, which was the secondary treating solution, was added in 5 c. c. portions with stirring after each addition. The milky suspension almost disappeared and was replaced by an almost colorless suspension. The volatiles were evaporated by heat and the material examined. The resulting material was readily friable. It was easily powdered by trie turation. Microscopic examination revealed a mixture of ball like masses and occasional fibrous fragments.
  • Example 34 if lactic acid is to be used and a powdered end product is desired the proportion of lactic acid of Example 34 is more desirable than that of Examples 35 and 36. Other examples (not listed) indicate that an excess of lactic acid provides a rubber like end product.
  • a process of dispersing methylcellulose comprising dividing and opening up the fibers and fibrils of'methylcellulose by treatment thereof with chloroform; adding a petroleum distillate having a minimum boiling point about C. above the first mentioned dispersing agent; and consecutively removing the dispersing agents by evaporation whereby the residue is recovered from the petroleum distillate and the fibers and fibrils of the methylcellulose are maintained in a divided and opened state.
  • a process of treating methylcellulose which comprises subjecting the methylcellulose to the action of an evaporatable, organic, liquid, swelling agent therefor, thereby dividing and opening up its fibers and fibrils; mixing with the methylcellulose and swelling agent a liquid material s swelling agent present inthe inner structure of the methylcellulose mass; and thereafter consecutively removing the swelling agent and petroleum' distillate from the methylcellulose, thereby obtaining as a solid residue a fiufiy, porous, methylcellulose product, the fibers and fibrils of which are maintained in a divided and opened condition.
  • a process of treating methylcellulose which A comprises subjecting the methylcellulose to the.
  • a process of treating methylcellulose which comprises subjecting the methylcellulose to the action of an evaporatable, organic, liquid, swelling agent therefor, thereby dividing and opening up its fibers and fibrils; mixing with the methylcellulose and swelling agent a liquid material which is soluble in, and has a boiling point about 15 C. above that of the swelling agent but which is substantially a nonsolvent for the methylcellulose, thereby substantially-replacing with the liquid material the organic swelling agent present in the inner structure of the-methylcellulose mass; and thereafter consecutively removing the swelling agent and liquid material from the methylcellulose, thereby obtaining as a solid residue a fluffy, porous, methylcellulose product, the fibers and fibrils of which are maintained ina divided and opened condition;
  • a process of treating methylcellulose which comprises subjecting the methylcellulose to the action of methylene chloride functioning as anevaporatable, organic, liquid, swelling agent therefor, thereby dividing and opening up its fibers and fibrils; mixing with the methylcellulose and swelling agent petroleum distillate having a minimum boiling point about 15 C. above the methylene chloride, thereby substantially replacing with petroleum distillate the organic material the organic swelling agent present in the inner structure of the methylcellulose mass;
  • methylcellulose is substantially a nonsolvent for the methylcellulose, thereby substantially replacing with the liquid material the organic swelling agent present in the inner structure of the methylcellulose mass; adding water; and thereafter consecutively removing the swelling agent, liquid material, and water from the methylcellulose, thereby obtaining as a solid residue a fiufi'y, porous, methylcellulose product, the fibers and fibrils of which are maintained in a divided and opened condition.
  • a process of treating methylcellulose which comprises subjecting the methylcellulose to the action of an evaporatable, organic, liquid, swelling agent therefor, thereby dividing and opening up its fibers and fibrils; mixing'with the methylcellulose and swelling agent a liquid material which is soluble in the swelling agent but which is substantially a nonsolvent for the methylcellulose, thereby substantially replacing with the liquid material the organic swelling agent present in the inner structure of the methylcellulose mass; adding a surface active agent and while the fibers and fibrils of the methylcellulose are divided and opened; and thereafter consecutively removing the swelling agent and liquid material from the methylcellulose, thereby obtaining as a solid residue a flufiy, porous, methylcellulose product, the fibers and fibrils of which are maintained in a divided and opened condition. 7
  • a process of treating methylcellulose which comprises subjecting the methylcellulose to the action of an evaporatable, organic, liquid, swell ing agent therefor, thereby dividing and opening up its fibers and fibrils; mixing with the methyl- 21 cellulose and swelling agent a liquid material which is soluble in the swelling agent but which is substantially a nonsolvent for the methylcellulose, thereby substantially replacing with the liquid material the organic swelling agent present in the inner structure of the methylcellulose mass; adding a binder for the end product and while the fibers and fibrils of the methylcellulose are divided and opened; and thereafter consecutively removing the swelling agent and liquid material from the methyl cellulose, thereby obtaining as a solid residue a flufl'y, porous, methylcellulose product, the fibers and fibrils of which are maintained in a divided and opened condition.
  • a process of treating methylcellulose which comprises subjecting the methylcellulose to the action of an evaporatable, organic, liquid, swelling agent therefor, thereby dividing and opening up its fibers and fibrils; mixing with the 20 methylcellulose and swelling agent a liquid material having a boiling point about 15 C. to about 20 C. above that of the swelling agent and which is soluble in the swelling agent but which is substantially a nons'olvent for the methylcellulose, thereby substantially replacing with the liquid material the organic swellin 22 agent present in the inner structure of the methylcellulose mass; adding a medicament while the said methylcellulose is Present in at least said organicliquidand while the fibers and REFERENCES CITED
  • the following references are of record in the file of this patent:

Description

Patented July 1, 1952 PROCESSING METHYL CELLULOSE AND THE PRODUCTS THEREOF Charles W. Abbott, Seattle, Wash, assignor, by decree of distribution, to Inez M. Abbott No Drawing. Application August 16, 1947, Serial No. 769,071
Claims.
My invention relates to a process of treating methylcellulose and the products thereof.
More particularly, my invention includes the dispersing or dividing of methylcellulose. Methylcellulose disperses very slowly in a liquid, and in accordance with prior art practices, the residue becomes a tough, membranous mass upon evaporation of the liquid used during disper- S1011.
It is the object of my invention to provide an absorbent material which includes therein methylcellulose in a condition to rapidly absorb various liquids.
As an illustration of my invention, but not as a limitation thereof, except where required by the appended claims, the invention will be described in connection with the preparation of surgical dressings, fabrics, tissues and the like, which include methylcellulose, or the fibers or fibrils thereof, in an open or divided state.
It is the object of my invention to provide a process for the opening up or dividing of methylcellulose, or the fibers or "fibrils thereof, in a liquid and for the recovering or maintaining the same in an open or divided state.
I have found that methylcellulose treated in accordance with my process has a greater capacity for absorbing liquids and at the same time has a more rapid rate of absorption than methylcellulose in the state or condition heretofore available.
Another particular characteristic of methylcellulose treated in accordance with my invention is that it' rapidly combines with liquids to form a gel, which liquids include :body fluids and body exudates. This particular characteristic of the product of my process makes the product especially useful in medical dressings. These medical dressings may include other carrier means or the methylcellulose may function as the surgical dressing. One of the forms of surgical dressings made in accordance with my invention is a powdery or fiber-like material which may be applied directly to burns or wounds in first aid or in subsequent treatment thereof. Another form thereof is where such product is incorporated in a dressing. or used to absorb drainage. For example, it may be employed in connection with a tapped, infected lung, osteomyelitis and other types of infection where we have a leakage of body fluids which are desired to be absorbed.
In the prior art treatment of burns, tissues form on the surface and are known as an eschar. This eschar is a layer of consolidated body exudates and dead tissue. Often under the eschar, bacteria develop and are protected before detection thereof, and before proper medicaments are disposed in reacting relation therewith.
One of the objects of this invention is to provide a medicated methylcellulose dressing made in accordance with my invention and which will function to supplant or take the place of the eschar and will further function to absorb the body exudates and thus permit the body tissues to heal in the absence of a true eschar.
In accordance with one presently accepted practice for the treatment of burns, a solution of tannic acid or asolution of silver nitrate is applied, or they areconsecutively applied. With this treatment, a tough, leathery-dike coating or eschar develops and often bacteria develop under the surface of this eschar. With the use of products of my invention, a relatively thin and soft protective layer may be formed, but it is of a character to absorb body exudates. Also, products of my invention comprise included medicaments disposed to readily react with injured tissues. Thus, I am able to obtain not only the effect of the medicaments, but to provide an exeluding layer which assists in preventing bacterial development.
It is a characteristic of the product of my invention that it is substantially inert to usual medicaments and body fluids, and thus is not conducive to complications or reactions, and has the physical characteristic of bringing about absorption of body exudates and providing a protective envelope. The product of my invention is not only inert, non-toxic, and non-irritating to burns, Wounds or body tissues but has other desired properties. These include absorption properties, ability to hold medicaments in a Well divided state and to effectively release the medicamcnts upon wetting of the product, ability to gel, and to form a protective envelope.
Methylcellulose is readily obtained commercially and is generally sold in types having difierent viscosities. For example, Dow Chemical Company sells methylcellulose under the trade name of Methocel and it is available on the market in several viscosities or types, as: 12, 25, 100, 400, 1560 and 4000 centipoises. The literature of Dow Chemical Company states that Methocel is synthesized from highly purified cellulose by interaction with caustic soda and methyl chloride, and that Methocel pharmaceutical grade is neutral, odorless, tasteless and completely inert. In my invention, I may use methylcellulose regardless of its viscosity in appropriate formulas.
In my invention I'firs't subject methylcellulose to what I will term a primary treating solution, or an organic dispersing agent. This solution functions as a dispersing and probably as a swelling agent and opens up or divides the methylcellulose, or the fibers or fibrils thereof. Preferably, I employ pharmaceutical grade methylcellulose either as obtained on the market or after the same has been mechanically sub-divided as by treatment in a hammer mill.
The said primary treating solutions comprise chloroform, methylene chloride, ethyl acetate, methyl acetate, methyl lactate, ethyl lactate, lactic acid, or a combination of such agents. Preferably, there is also present a small quantity of water as apparently water present in small quantities aids in the primary treatment. I have found that where I treat methylcellulose with such a primary treating solution, there is swelling, dividing or opening up of the methylcellulose, or the fibers or fibrils thereof. However, if methylcellulose is subjected to the action of my primary treating solution and then the volatiles are evaporated, I find that the residue is a harsh, tough and membranous mass, and is no more suited to the objects of my invention than the original methylcellulose. While I have set forth typical examples of solutions which may function as my primary treating solution, it is to be eX- pressly understood that I am not limited thereto and may employ solutions which will provide the same results to varying degrees. In selecting such primary treating solutions, I have selected those having relatively low boiling points so that the solutions selected as secondary treating solutions may have boiling points which are not too high. In this respect the secondary treating solution will always have a higher boiling point than the primary treating solution. Also, the primary treating solution must have the action on the methylcellulose, or fibers or fibrils thereof as above stated.
The step of expanding the methylcellulose, or the fibers or fibrils thereof, is followed by a second step or treatment with what I term a secondary treating solution, or an organic dispersing agent, to retain the methylcellulose, or the fibers or fibrils thereof in a divided or opened state. The secondary treating solution, or organic dispersing agent, must be miscible to the primary treating solution.
While the secondary treatment has for its purpose the maintaining of the said divided state, :yet most of the agents I have employed provide a further dividing or opening up of the methylcellulose in this secondary step. Some of the agents employed in this secondary step include fractional distillates of petroleum. The boiling point thereof must be higher than the boiling point of the primary treating solution. Thus, fractional petroleum distillates having a boiling point in the range of 40 C. to 180 C., will be within the range of my invention as secondary treating solutions and the particular one selected in a given case must be selected in accordance with the boiling point of the primary treating solution. Other secondary treating solutions which I have employed include coal tar distillates comprising benzene, toluene, and dimethyl benzene.
In my invention, I disperse the methylcellulose in the primary treating solution and cause a dividing or opening up of the methylcellulose, or its fibers or fibrils. Then in the presence of a secondary treating solution having a boiling point of approximately 15 above the boiling point of the primary treating solution, I remove the primary treating solution and then finally recover the divided methylcellulose from the secondary treating solution. One way of expressing the matter is that I have discovered that I can recover the divided methylcellulose when substantially in the presence of a secondary treating solution without causing the methylcellulose to coalesce into a tough, membranous mass. When 'an attempt was made to recover the divided methylcellulose from the primary treating solution, it was found that the residue was a tough membranous mass. By providing a minimum difference in boiling points between the primary treating solution and the secondary treating solution of substantially 15 C., then substantially all re- 'covery of the divided methylcellulose will be made after the primary treating solution has been 'driven OE and the ill effects of the primary treating agent, if used alone (for example, providing a tough membranous residue), will be eliminated.
As the recovered, divided methylcellulose of my invention is inert, its Value for medicinal purposes may be augmented when medicaments are added thereto. medicaments to the divided methylcellulose of this invention is to add the medicaments when the primary and secondary treating solutions are present. When the methylcellulose is in the presence of the primary and secondary treating solutions, it has reached substantially its greatest state of dispersion and obviously at such time better dispersion of the medicaments will obtain,
. thus providing a better and more uniform prodnot. The medicaments to' be added must be at least dispersible in the treating solutions and thus the treating solutions function to provide more complete dispersionv of the medicaments in the methylcellulose.
Previously, I stated that there should be substantially a minimum of approximately 15 C. variation in the boiling points between the primary and secondary treating solutions to insure that the final recovery of the divided methylcellulose would be from the secondary treating solution. This of course included the premise that the volumes of treating solutions would be in the range of the minimum volumes required. I have found that practical results obtain under such conditions when this variation is reduced to very slight difierences but this requires more exacting technique. If a very substantial excess of the secondary treating solution is employed, the difierence need be only a few degrees. As to the maximum variation between the boiling points of the primary and secondary treating solutions, I find no need to extend this beyond 20 C. to get consecutive removal of the treating solutions, and if further extended, I find two adverse results. First, there is a waste of energy and second, there will be a limiting of the types of medicaments which can be included, as fractions of the same may distill ofl with the inherently higher temperatures which must be maintained in the final recovery of the divided methylcellulose and medicaments from the secondary treating solution. "Of course, if the recovery of the divided methylcellulose is made at atmospheric pressure, we may have not only fractional distillation of medicaments, but may have damage to the medicaments caused by heat. Obviously, if recovery of the divided methylcellulose and the included medicaments is made at sub-atmospheric pressures, lower temperatures may be employed with less heat damage to the medicaments.
My preferable method of addin The medicaments, which can be incorporated inthe divided methylcellulose .of my invention when both the primary and secondary treating solutions are present, will of coursebe those which are not adversely afiected by such treating solutions. Due to the nature of the primary and secondary treating solutions, they will not form any substantial limiting factor as to the medicaments which may be employed. They are very stable chemical compounds and have little or no reaction with medicaments commonly employed in medical dressings. Of course, the medicaments commonly employed should be those which can be dissolved or at least dispersed in treating solutions to obtain the desired dispersion in the end product. Thus the medicaments should be added at least at no later stage than when some of the secondary treating solution is present and preferably when both treating solutions are present. While the medicaments can be added to the end product, this is not preferable as the dispersion thereof will not be as complete.
Preferably, I include a surface active agent, of either the cation or anionactive class, in products embodying my invention which are designed for medical uses as such agents augment the wetting action of the compounds by either water or body exudates. A typical agent is dioctyl sodium sulfa succinate, commonly sold as "OT 100.
Typical medicaments which may be added to the divided methylcellulose of my invention and their properties therein comprise: glycerol, it is hygroscopic, it is a plasticizer forming a tougher and softer protective coating, it is a dispersing agent for many medicaments, and is anti-bacterial; polyethylene glycol, it is soluble in both oil and water and functions as a dispersing agent for other medicaments; boric acid; sulfa compounds, as sulfanilamide, sulfathiazole, sulfapyridine, etc.; merthiolate; mercurochrome; hexylresorcinol; dyes, as azo dyes, acridine dyes, fluorescein dyes, rosiniline dyes, phenolphthalein dyes, and miscellaneous dyes; local and topical anaesthetics; digestants, as pancreatin, pepsin, bromelin and papain; antibiotic substances, as penicillin and salts thereof, gramacidin and salts thereof, tyrothrici'n and salts thereof, streptomicin and salts thereof, and subtilin and salts thereof; and cell proliferants, as allantoin, urea, uric acid, and chlorophyll. These are only examples and the medicaments are not limited thereto.
In order that the practicing of my invention may be better explained and illustrated, I will set forth a number of examples with proportions and with summary results, but it is to be understood that such examples are not a limitation of my invention except when required by the appendedclaims and are to be considered illustrative.
Example 1 Methylcellulose, 4000 centipoises gms 2.5 Activated charcoal gm .1 Chloroform c. c 40 Petroleum distillate, B. P. 77 C. to 110 C.
I indicative of one medicament, activated charcoal was employed and its chief characteristic was that of absorbing odors. After the addition of the secondary treating solution, the mixture was heated. ten minutes at 130C. The chloroform, due'toitslower boiling point, was first driven off and finally the petroleum distillate was driven off. The residue remaining was in the nature of a soft felt-like pad. It was used as a surface coating on a gauze bandage and the gauze side of the bandage was placed in closed proximity to the wound of an ulcer case. The product readily gelled on the surface of the gauze bandage and functioned as a carrier for the charcoal, and in turn the charcoal tended to absorb body odors.
In examples hereinafter given, the centipoise of the methylcellulose employed will be abbreviated to c. p, Also, the details of the action of the primary treating solution and the secondary treating solution will be somewhat abbreviated but the nature of each will be generally indicated. Also, the petroleum distillate which was used in the following examples had a boiling point of 77 C. to 110 C. unless otherwise indicated.
Example 2 x Methylcellulose, 4000 cp. gms 2.5 Glycerol m 0.5 Ethyl cellulose (19% sol. in chloroform) $1115.. 2 Chloroform c. c Petroleum distillate c. c
The chloroform was used as the primary treating solution and the methylcellulose and ethyl cellulose solution was placed therein. The said agents were allowed to remain in contact for about thirty minutes and with agitation and the dispersion appeared complete. Thepetroleum distillate was added as the secondary treating solution. The dispersion was filtered and the treating solutions were partly removed by filtration. Then after air drying and finally by heating for ten minutes at a temperature of C. to remove traces of petroleum distillate, a final product was obtained which was a compact and coherent pad. It was not too friable and was slow to absorb water. It was a useful product but not a preferred form. The ethyl cellulose functioned as a binder to hold the end product in a form retaining pad.
Example 3 Methylcellulose, 4000 cp gms l0 Activated charcoal gms 7 Ethyl cellulose (10% sol. in chloro- -'form) gms 1 Chloroform c. c 160 Petroleum distillate c. c
The chloroform was employed as the primary treating solution and the methylcellulose and ethyl cellulose solution were placed therein. The activated charcoal was added and well dispersed. Petroleum distillate was added as the secondary treating solution. The material was removed to a form and air dried and then heated to 100 C. to remove traces of the petroleum distillate. This material formed a compact pad which did not absorb water readily but which, because of the presence of activated charcoal, readily absorbed noxious odors from putrescent wounds.
Example 4 Methylcellulose, 4000 cp gms 30 Glycerol gms 3 OT 100 gms .3 Chloroform c. c 480 Petroleum distillate c. c 360 which were rather slow to absorb water.
ture. The OT 100 had been previously dissolved in the chloroform. The petroleum distillate was used as the secondary treating solution. The mixture was poured into a form and partly dried by filtration and then dried by applying heat at 100 C. This material formed pads or dressings Their texture was not as soft or fluffy as other examples of my invention.
Chloroform in which the OT 100 had been dissolved was used as the primary treating solution and the methylcellulose was placed therein. The boric acid was triturated with the glycerol and added to the above mixture. Petroleum distillate was used as the secondary treating solution. The mixture was poured out in forms and a portion of the treating solutions were removed by filtration. The material was then divided and one portion permitted to air dry to complete removal of the treatingsolutions. The second portion was dried at a temperature of 90 C. No difference was noted in the final resulting material. The material was readily teased apart by means of a wool card. This final material was a fine powdery fiuif. It wet slowly with water.
It will be noted that heretofore a portion of the treating solutions were removed by filtration, and a final treatment by air drying or by treating with heat. This resulted in a partial loss of medicaments. Hereafter all treatments will be by partial removal of treating solutions by vacuum and the removal of final traces of treating solutions by heat.
The chloroform, in which had been previously dissolved the OT 100, was used as the primary treating solution. The boric acid was triturated in the glycerol and the mixture added to the dispersed methylcellulose in the chloroform. The petroleum distillate, which was used as the secondary treating solution, was added and the mass thoroughly mixed by stirring. The mixture was subjected to the heat of boiling water and a vacuum applied. The treating solutions were recovered, fractionated and reused. The final traces of the treating solutions were removed by subjecting the resulting material to a heat of 95 C. After a complete drying, the material was teased apart by means of wool cards. The material was a soft, fluffy mass. This material was divided into ten gram portions which were enclosed in gauze to form a medicaldressing. The material was readily wet by water. A clinical test was made and the attending nurse reported that said dressings were: Two or three times as effective as ordinary dressings in absorbing body exudates in a case of empyema.
, 2 Example 7 Methylcellulose; 4000 cp gms 30 Glycerol s 7.5 Mercurochrome gms OT 100 ems ,3 Chloroform c. c 400 Petroleum distillate c. c 400 Chloroform, in which had been dissolved the OT 100, was used as the primary treating solution. The mercurochrome was triturated with the glycerol and added to the dispersed methylcellulose the chloroform. The glycerolmercurochrome mixture formed a gummy mass which was hard to disperse. The petroleum distillate was used as the secondary treating solution and was added next. The mixture was treated to the heat of boiling water and a vacuum applied. The volatile solvents were recovered, fractionated and reused. The mass was treated with a heat of C. to remove final traces of treating solutions. The mass was then teased apart by means of wool cards. The resultin material was a soft fiuify mass which was readily soluble in water.
chloroform, in which had previously been dissolved the OT was used as the primary treating solution. The pancreatin and sodium bicarbonate (a combination medicament) was triturated with the glycerol. This formed a mass which was dispersed with difficulty in the dispersed methylcellulose in chloroform. Petroleum distillate was used as the secondary treating solution and was added after the dispersion indicated above. The previously mentioned procedure of removal and recovery by vacuum was followed. Final traces of treating solutions were removed by heat. The material was teased to a soft fiufi? by means of wool cards and made into medical dressings surrounded with gauze. The material was readily soluble in water. A clinical test was made and the attending nurse reported that by use of the dressings: the necrotic surface of the ulcer was very much softened and was removed when the dressing was remov Example!) Methylcellulose, 4000 cp. gms 30 Glycerol gms 7.5 0'1 100 gms .6 Chlorophyll (water soluble) gms .6 Chloroform c. c 400 Petroleum distillate c. c 400 Chloroform was used as the primary treating solution. In the chloroform had been previously dissolved the OT 100. The chlorophyll was triturated with the glycerol and the mixture added to the methylcellulose dispersed in the chloroform. The secondary treating solution, petroleum distillate, was added and the whole thoroughly mixed. The treatment by vacuum and heat was followed. The material was teased to a soft fluff. The material was soluble with clifiiculty in water due to the presence of chlorophyll.
Emample 10 Methylcellulose, 4000 cp -gms 30 Glycerol gms 7.5 '1 100 ems" .'3- Allantoin gms .12 Chloroform c.c 400 Petroleum distillate c. c 400 Chloroform was used as-the primary treating solution. The OT 100 had been previously dis solved in the chloroform. The allantoin was triturated in the glycerol. A fair suspension was formed. This suspension was thoroughly mixed with the dispersed methylcellulose in chloroform. Petroleum distillate. as the secondary treating solution, was added. .The petroleum distillate was thoroughly mixed with the mass. The procedure of removal by vacuum and heat was followed. The mass was teased to a fiufiy mass. It was readily soluble in water. Allantoin is a cell proliferant. It was added in this example to promote cell growth.
Example 11 ethylene glycol was substituted for glycerol.
This resulted in a uniform dispersion of the medicaments and dispersion was readily obtained.
Example 12 Methylcellulose; 25 op gms 10 Pancreatin mm 1.5 Sodium bicarbonate gms 6 Polyethylene glycol, M.- W. 1500 gms OT 100 gms .2 Chloroform c. c 250 Petroleum distillate c. c 250 Chloroform, in which had been dissolved the CT 100, was used as the primary treating solution. The pancreatin and sodium bicarbonate was triturated with the polyethylene glycol (acting as a dispersing agent for the medicaments) until a uniform mixture was prepared. After the methylcellulose had been dispersed in the chloroform, the polyethylene glycol-pancreatin-sodium bicarbonate mixture was added and was readily and uniformly dispersed. The secondary treating solution, petroleum distillate, was next added and thoroughly dispersed. The removal by vacuum and heat was followed. .The resulting material was teased apart with wool cards to a powdery fluffy mass. It was quickly and readily soluble in water.
Example 13 Methylcellulose, 25 cp gms Chlorophyll (water soluble) gms .9 OT 100 gms .3 Polyethylene glycol, M. W. 1500 gms 5 Petroleum distillate c. c.. 250 Chloroform c. c 250 The chloroform, in which had been dissolved the OT 100, was used as the primary treating solution- The ylcellulose was immersed in the chloroform and the mixture was shaken until of. chlorophyll-polyethylene glycol was addedto the methylcellulose in the 'chloroformand the mixture was stirred until dispersion appeared uniform. The chlorophyll was easily dispersed by this treatment. Petroleum distillate was added as the secondary treating solution and was uniformly dispersed by shaking. The treating solutions were removed by vacuum and heat treatment. The remaining material was readily fluffed by the use of wool cards to a fibrous powdery mass. When tested for solubility in water the material dissolved to a gel at a very rapid rate. This result is in contrast to the Example 9 where it was discovered that chlorophyll increased surface tension and delayed dispersion. The only changes (over Example 9) were the use of methylcellulose 25 cp., polyethylene glycol M. W. 1500, and an increased amount of CT 100. This material may be used, as an example, as a dressing for chronic, necrotic ulcers.
- ExampZe M Methylcellulose, 25 cp gms 10 Glycerol gms 2.5 Allantoin gms .2 OT gms .3 Polyethylene glycol, M. W. l500 gms 2 Chloroform c. c Petroleum distillate c. c 150 The chloroform was used as the primary treating solution. The GT 100 was'dissolved in the chloroforma convenient manner of dispersion. The methylcellulose was immersed in the chloroform for approximately thirty minutes and the dispersion appeared complete. Dispersion of the methylcellulose was hastened by agitation.
The allantoin and glycerol were triturated in the polyethylene glycol until a uniform mixture was obtained and the mixture was then added to the methylcellulose which had been dispersed in chloroform. The materials were intimately mixed or dispersed by stirring. The petroleum distillate was added as the secondary treating solution and was dispersed by shaking. The volatile solutions were removed by vacuum-heating treatment. The material was easily teased to a fiuffy material by carding. The medicated material was readily soluble in water.
This material when applied with a little water to cuts, wounds, abrasions and burns forms a neat, compact, synthetic protective coating due to the presence of methylcellulose. Also the allantoin provides conditions augmenting healing. Small cuts inflicted during shaving stopped bleeding almost instantly and were healed in twenty-four hours and they were not re-opened on shaving the second day.
The chloroform, in which the OT 100 had been dissolved, was used as the primary treating solution. The methylcellulose was immersed in this primary treating solution and was shaken for about thirty minutes and dispersion seemed complete. The glycerol and allantoin were triturated into the polyethylene glycol until a uniform mixture was prepared. This mixture was incorporated in the methylcellulose-chloroform mixture by stirring until uniformly dispersed. The tyrothricin (in alcohol) was added to the mixture and dispersed by shaking and stirring. The petroleum distillate was added and dispersed by shaking for about ten minutes and a uniform mixture was obtained. The volatiles were removed by vacuum-heat treatment. The material was flufied to a finely fibrous mass. This example illustrates the use of an antibiotic substance. Tyrothricin, properly applied, is active in destroying and inhibiting the growth of gram-positive bacteria which most often cause acute infections. A laboratory test of this medicated material against Staphylococcus aureus proved it to be effective in very low dilutions.
No special care was used in preparing this material under aseptic conditions but a culture of the material failed to produce any colonies.
, In applying a product of my invention to small wounds, the wound may be moistened with a drop of water, if not already moist. A small portion of the material is placed on the surface of the wound and a few drops of water may be added if needed. A gel is formed and should be spread to provide appropriate coverage. The protective layer is permitted to dry and forms a seal over the wound. If there be need, an oiled dressing may be placed over the protective layer to prevent sticking to clothing, etc.
This dressing has been proven to be very effective in cases of boils. Infection has been rapidly reduced with rapid healing. In the case of an infected abrasion a protective layer of the material was applied as has been indicated. The infection subsided rapidly and healing was prompt.
In a case of a blister caused by the use of an adhesive bandage, an application was made as indicated. The wound healed rapidly without infection and without a scab.
The material has also been proven effective in cases of burns. Infection is reduced and healing progresses without a scab. The surface of the tissues may be seen through the dressing.
The foregoing examples illustrate some of the medicaments which can be incorporated into the products embodying my invention. Furthermore, they illustrate the use of chloroform as a primary treating solution and petroleum distillate as a secondary treating solution. In some of the examples, glycerol and/or polyethylene glycol has been employed. Also, they indicate a differential in boiling points between the primary treating solution or solutions and the secondary treating solution or solutions which will be in the neighborhood of C. and specifically 158 C.
In order to determine other treating solutions other tests were made. The following example indicates the use of methyl acetate as a primary treating solution and benzene as a secondary treating solution:
Example 16 Methylcellulose, 4000 cp gms 0.5 Methyl acetate c.c Benzene 0.0.. 20
The methyl acetate was added to the methylcellulose and allowed to stand for one hour.
Methyl acetate functioned as a primary treating solution. Then the benzene was added and the material was allowed to stand for another hour. The volatiles wereremoved by heat and the end product was soft and fluffy. In this particular example and others following, no medicaments were used as a determination wa being made. for treating solutions. As the previous examples indicated that the end product was inert to the various medicaments to be added, thus I was determining agents and formulations to obtain the proper physical characteristics of the end product.
Example 17 Methylcellulose, 4000 cp gms 0.5 Chloroform c. c 30 Toluene c.c 30
The chloroform was added to the methylcellulose and permitted to stand two hours. Then toluene was added and the mass was permitted to stand fifteen hours. The volatiles were evaporated and the residue was soft and fluffy. It shredded to form a filamentous mass. It was thus established that toluene is one Of the secondary treating solutions which may be used in my invention.
Example 18 Methylcellulose, 4000 cp gms 0.5 Chloroform c.c 30 Benzene c. c 30 The chloroform was added to the methylcellu lose and permitted to stand forty-four hours. The benzene was added and the mass was permitted to stand five hours. The volatiles were evaporated and the residue was a short felt and not fiuffy. Upon carding the material was fluffy but there were traces of lumps. This example indicates that benzene can be used in my invention as a secondary treating solution. Furthermore, the differential in boiling points between chloroform and benzene is approximately 8 C. I thus established that with as little as 8 C. between the boiling points I could first remove, dur ing evaporation, the primary treating solution and have the final recovery in the presence of the secondary treating solution.
Example 19 Methylcellulose, 4000 cp gms 0.5 Chloroform c.c 25 Toluene c.c 15
Example 20 Methylcellulose, 4000 op. gms 0.5 Methylene chloride c.c 35
Toluene c.c 30
The methylene chloride was added to the methylcellulose and shaken vigorously. The dispersion was permitted to stand forty-four hours and the material appeared well dispersed. Toluene was added and the dispersion permitted to stand four hours. Upon evaporation of the volatiles, the residue was soft and felt-like and Example 21 Methylcellulose, 4000 op. -gms 0.5 Methylene chloride c.c 30 Petroleum solvent o.c- 30 Added 30 c. c. of methylene chloride to the methylcellulose and permitted the mass to stand four hours. Then added 30 c. c. of petroleum solvent and permitted the mass to stand two hours. The volatiles were evaporated and the material was soft and fluffy. The material was slightly lumpy when carded.
Example 22 Methylcellulose, 4000 cp gms 0.5 Methylene chloride c.c- 15 Chloroform c.c 15 Petroleum solvent c.c 30
Fifteen c. c. of methylene chloride and 15 c. c.
, of chloroform were added to the methylcellulose and permitted the mass to stand two hours.
Example 23 Methylcellulose, $000 cp gms 0.5 Methylene chloride c.c l Chloroform c.c
Toluene c. c 30 Methylene chloride and chloroform were added to methylcellulose and let stand one hour. Then added the toluene and let stand one hour. Evaporated the volatiles and the material could be readily fluffed by cards. This example v indicated another primary treating solution.
was a soft, short fibered material and could be I fiulfed by cards.
Example 24 Methylcellulose, 4000 cp gms 0.5 Methylene chloride c.c 15 Chloroform ;c.c 15 Benzene c.c 3O
Methylcellulose, 4000 cp gms 0.5 Toluene c.c 30 OT 100 0.0188 Methylene chloride c.c 10 Chloroform e.c 20 Water c.c 1
Placed the methylcellulose and the OT 100 in a flask and added thirty small sized ball bearings. Next, the mass was thoroughly shaken. The ball bearings were employed to aid in the dispersion. Added the water and provided further agitation. Next, added 10 0.0. of toluene and continued agitation. Then the balance of the toluene was added. Upon evaporation of the volatiles, the residue was soft and fibrous and .could be carded to provide a soft fine. fluff.
Other comparative tests indicated that thelwater, under conditions mentioned, was helpful in dispersing the methylcellulose.
Example 26 Methylcellulose, 4000 cp gms 0.5 Chloroform c.c 20 Petroleum distillate c.c 30 Water -P c.c 1 OT gms .02
The methylcellulose and the OT 100 were placed'in a mortar and some of the chloroform was added. The mass was triturated and the balance of the chloroform was added periodically in small amounts. Then the mass was transferred to a cylinder and the petroleum distillate added and the mass well shaken. Upon evaporation of the volatiles, the residue was a soft, short fiber felt. It carded well. From this example and other similar examples it was determined that trituration before adding the secondary treating solution was helpfuL- Itappeared unsatisfactory to triturate after the secondary treating solution had been added but shaking whilethe secondary treating solutions are present proved helpful. Water again appeared helpful when added to the primary treating solution.
Example 27 A series of tests were run employing 0.5 gm. of methylcellulose; 0.02 gm.-of OT 100; 1 c. c. of water and 20 c. c. of chloroform. The amount of petroleum solvent was varied and thus it was found that the lower limit of the petroleum distillate in this combination was approximately 10 c. c. and that optimum results obtained by the use of 15 c. c. or over. Also it was found that by keeping the other factors constant except the water, the maximum amount of water which can be incorporated for optimum results was 1 c. c. Un der such circumstances the amount of methylcellulose was 0.5 gm.; OT 100 was .02 gm.; chloroform was 20 c. 0.; and petroleum distillate was 30 c. c.
Example 28 In order to determine the range of the fraction of petroleum distillate which could be used and to determine whether methylcellulose of different viscosities could be employed, petroleum distillate having a boiling point in the range of 36 C. to 60 C. was employed and methylcellulose having a viscosity of 25 cp. was employed in this example. In the previously mentioned examples where petroleumdistillate was used, its boiling point was 77 C. to C. so as not to introduce a variable in this respect, as other factors were being determined.
Methylcellulose, 25 cp gm 0.5 Methylene chloride c. c 30 Petroleum distillate, B. P. 30 C. to
60 C c. c 30 The methylene chloride was added to the methylcellulose and shook for thirty minutes with balls present to aid in the agitation. Then the petroleum distillate was added and was shaken for fifteen minutes and then let stand one hour. After evaporation of the volatiles, the residue was soft and fluffy and did not need carding, but does card well. The methylene chloride has a boiling point of 40 C. and the final boiling point of the fraction of petroleum distillate employed was sufiic'ientig: higher so that the final recovery of the'residue was in the presence of the petroleum distillate.
This and other tests indicated that I can employ in my invention fractional distillates of petroleum having a boiling point in the range of 40 C. to 180 C. providing the proper primary treating solution is employed to give a difierential so that the final recovery of the residue is in One 0. c. of ethyl acetate and gms. of methylcellulose were added to 1 c. c. of water in a mortar. The same was triturated to a paste. Then 5 c. c. of chloroform, to which had been added the OT 100, were introduced with l c. c. of chloroform at a time and with trituration after each addition. Then added 5 c. c. of dimethyl benzene and stirred well. This established the use of ethyl acetate as a primary treating solution and benzene as a secondary treating solution. Also, this example evidenced a further phenomenon in that the product appeared somewhat fibrous but well comminuted under a microscope. This material is very useful in my invention and it appears that a long fibrous character is not essential to a successful product.
I have employed methylcellulose as is obtained on the market or have mechanically sub-divided it by treatment in a hammer mill. For some uses of my product, the finer the particle size the more utility the same will have. I have found that by mechanically sub-dividing, I can get a powder of approximately cosmetic grade. By use of the last example the pieces are extremely small but yet their fibrous character can be determined by a microscope.
The same procedure was followed in both Examples 30 and 31 and the methylcellulose was placed in a mortar and the ethyl lactate and CT 100 were added. To these also was added the water. The mixture was then triturated to a paste and chloroform was added in portions of 5 c. 0. each, with trituration between each addition. The mixture apparently passed through a gel state. Apparently ethyl lactate, water and chloroform formed in combination the primary treating solution. Then the petroleum distillate was added as the secondary treating solution and this was done by adding portions of '5 c. 0. each with stirring between each addition. The mixture passed from a milky suspension to an almost transparent suspension. After evaporation of the volatiles, the residue was a very friable mass and upon trituration became a powder of almost cosmetic grade. The material was very soluble in liquids and when sprinkled on the surface of the water it displayed great surface activity, e. g., broke surface tension of the water. As the boiling point of ethyl lactate is 154 C. it is necessary to employ a secondary treating solution having a rather high boiling point. If medicaments are to be incorporated in the end product, it would appear advisable that the final recovery be made at pressures less than atmospheric so as to remove possible harming of a medicament by higher temperatures. Obviously, the boiling points will be reduced when sub-atmospheric pressures are involved.
Upon examination of the material under a microscope at 110 and 550 diameters or magnifications, it was discovered that the fibrous structure of the methylcellulose had entirely disappeared and had been replaced by a round structure shaped like a ball. Other fragments appeared to be groups of balls and many single round bodies were found. These appeared either as one large ring with a much smaller center ring or a large ring with a small solid center. These Examples 30 and 31 indicated other treating solutions and also indicated that the end product of my process may be a true powder and not fibrous or a comminution thereof.
Example 32 Placed the methylcellulose and CT in a mortar and added thereto the primary treating solutions which consisted of methyl lactate, water and chloroform. The methyl lactate was added first and the water next. This was insufiicient to completely wet the mass because of the tendency of the methylcellulose to gel and prevent wetting. One 0. c. of chloroform was added and permitted to stand for a few minutes until the mass was wet. The mass was triturated and 9c. 0. of chloroform was added in 1 c. c. portions with trituration after each addition. In each case a stiff paste formed. Next 15 c. c. of chloroform was added in 5 c. c. portions with trituration after each addition. A white, milky suspension was formed. To this was added the secondary treating solution of petroleum distillate in 5 c. 0. portions withstirring after each addition. The suspension precipitated into small irregular masses, which were suspended in the treating solutions. The volatiles were removed by heat. The residue was a soft and very friable mass. It was easily powdered to a very fine soft powder. This was done with a rubbing or beating action without pressure to prevent packing.
A microscopic examination of the powdered material under magnifications of and 550 showed the material to be of irregular fragments. There were some balls but most of the fragments seemed to be groups of balls or pitted 75 masses. It was free of fibrous structure. It apparticular viscosity.
17 peared. as if the material hadwbeen exploded. After powdering it wet readily and had great surface activity. The fragments flew apart on the surface of thewaterasztheyflwet.
= or, crack when stirred- The remaining chloroform was added'in cc. portions with trituration to smoothness after each addition. A milky suspension was formed. The methyl lactate, water and chloroform constituted the primary treating solution in which the methylcellulose was dispersed.
To the suspension'there was added the petroleum distillate in 5 cc. portionswith stirring after each addition. The suspension lost the milky appearance and finally began toprecipita'te in small irregular clumps. i I
The volatiles were removed by evaporation with heat. The residue comprised a friable mass which was somewhat more compact than the residue obtained from methylcellulose op. 25. Trituration was required to pulverize the residue to a powder. The powder was of substantially the same quality as obtained from methylcellulose op. 25. It wet easily. 1
An examination under the microscope revealed substantially the same structure as obtained in Example 32. A few ball like portions were found. These had a circular edge with a light portion surrounding a dark center. For the most part the material consisted of pitted irregular masses. The later picture was seen under 550 magnifications and the former under 110 magnifications. No fibrous fragments were found.
Examples 32 and 33 thus indicated that methyl lactate can be employed in my invention and with satisfactory results. Again it appeared that the methylcellulose employed need not have any Example 34 Methylcellulcse, 25 .cp gms 0.5000 Water c. c 1 Latic acid gms 1 OT 100 ems .02 Chloroform c. c 25 Petroleum distillate, B. P. 120 C.- to
180 C. c.c 30
In this example the water, lactic acid and chloroform were used as the primary treating solution. The methylcellulose was placed in a mortar and to it were added the water, OT 100 and lactic acid and also 5 c. c. of chloroform. (The chloroform was added at this time because the water and lactic acid were not enough to 18 wet the methylcellulose.) triturated to a stiff paste. Then the chloroform was added in 5 c. c quantities with trituration after'eachaddition. A milky suspension was formed. The petroleum solvent, which was the secondary treating solution, was added in 5 c. c. portions with stirring after each addition. The milky suspension almost disappeared and was replaced by an almost colorless suspension. The volatiles were evaporated by heat and the material examined. The resulting material was readily friable. It was easily powdered by trie turation. Microscopic examination revealed a mixture of ball like masses and occasional fibrous fragments.
4 Examples 35 and 36 Methylcellulose, 25 cp gms 0.5000 Water c. c 1 Lactic acid ms 2 OT 10'0 ms .02 Chloroform c. c 25 Petroleum distillate; B. P. 120 C. to
180 C c. c 30 Methylcellulose, 4000 cp. gms 0.5000 Water s c. c 1 Lactic acid gms 2 OT ems .02 Chloroform c. c 25 Petroleum distillate, B. P. C. to
C c. c 30 In these two examples two variables were intro-. duced. First the amount of lactic acid was doubled in relation to the amount used in Example 34 and methylcelluloses of both low and suspension of the methylcellulose was thus formed in the primary treating solution. The petroleum distillate was added in 5 c. 0. portions with stirring after each addition. The suspension became almost transparent. Th volatiles were removed by evaporation with heat. The resulting product was a very friable mass. It was triturated to a powder which had a tendency to cling together which indicated that it was of a fibrous nature. Microscopic examination showed that there were some ball formations but a considerable portion consisted of fibrous fragments.
Thus if lactic acid is to be used and a powdered end product is desired the proportion of lactic acid of Example 34 is more desirable than that of Examples 35 and 36. Other examples (not listed) indicate that an excess of lactic acid provides a rubber like end product.
In Examples 29 to 36, the boiling points of the secondary treating solutions are relatively high and would thus limit the medicaments which could be added while the primary and secondary treating solutions are present. However, said examples produced an end product which was substantially a powder in form. I have found that if the end product is once reduced to powder f e. g., the end products of 29 to 36 inclusive) that this powder can be employed with the primary and secondary treating solutions of the previous examples and the powder form will still be re- The materials were end product and'then subject this powdered end product to primary and secondary treating solutions having lower boiling points and add the desired medicaments during this secondary treatment as most medicaments to be added will tolerate such lower temperatures. Then the end product will have incorporated therein the desired medicaments and will be of a powdered form.
Obviously,-changes may be made in the form, proportions,- and arrangements of the parts of my inventionwithout departing from the principles thereof, the above setting forth only preferred forms of embodiments of my invention.
I claim:
1. A process of dispersing methylcellulose comprising dividing and opening up the fibers and fibrils of'methylcellulose by treatment thereof with chloroform; adding a petroleum distillate having a minimum boiling point about C. above the first mentioned dispersing agent; and consecutively removing the dispersing agents by evaporation whereby the residue is recovered from the petroleum distillate and the fibers and fibrils of the methylcellulose are maintained in a divided and opened state.
2; A process of treating methylcellulose which comprises subjecting the methylcellulose to the action of an evaporatable, organic, liquid, swelling agent therefor, thereby dividing and opening up its fibers and fibrils; mixing with the methylcellulose and swelling agent a liquid material s swelling agent present inthe inner structure of the methylcellulose mass; and thereafter consecutively removing the swelling agent and petroleum' distillate from the methylcellulose, thereby obtaining as a solid residue a fiufiy, porous, methylcellulose product, the fibers and fibrils of which are maintained in a divided and opened condition.
6. A process of treating methylcellulose which A comprises subjecting the methylcellulose to the.
action of an evaporatable, organic,.liquid, swelling agent therefor, thereby dividing and opening up its fibers and fibrils; mixing with the methylcellulose and swelling agent a liquid material having a boiling point about 15 C. to about C. above that of the swelling agent and which is soluble in the swelling agent but which is'substantially a nonsolvent for the methylcellulose,
' thereby substantially replacing with the liquid which is soluble in the swelling agent but which is substantially a nonsolvent for the methyl-- cellulose, thereby substantially replacing with the liquid material the organic swelling agent present in the inner structure of the methylcellulose mass; and thereafter consecutively removing the swelling agent and liquid material from the methylcellulose, thereby obtaining as a solid residue a fiuffy, porous,.methylcellulose product, the fibers and fibrils of which are maintained in a divided and opened condition.
3. The methylcellulose product of the process of claim 1. c
4. A process of treating methylcellulose which comprises subjecting the methylcellulose to the action of an evaporatable, organic, liquid, swelling agent therefor, thereby dividing and opening up its fibers and fibrils; mixing with the methylcellulose and swelling agent a liquid material which is soluble in, and has a boiling point about 15 C. above that of the swelling agent but which is substantially a nonsolvent for the methylcellulose, thereby substantially-replacing with the liquid material the organic swelling agent present in the inner structure of the-methylcellulose mass; and thereafter consecutively removing the swelling agent and liquid material from the methylcellulose, thereby obtaining as a solid residue a fluffy, porous, methylcellulose product, the fibers and fibrils of which are maintained ina divided and opened condition;
5. A process of treating methylcellulose which comprises subjecting the methylcellulose to the action of methylene chloride functioning as anevaporatable, organic, liquid, swelling agent therefor, thereby dividing and opening up its fibers and fibrils; mixing with the methylcellulose and swelling agent petroleum distillate having a minimum boiling point about 15 C. above the methylene chloride, thereby substantially replacing with petroleum distillate the organic material the organic swelling agent present in the inner structure of the methylcellulose mass;
adding a medicament while the said methylcellulose is present in at least said organic liquid and while the fibers and fibrils are divided and:
which is soluble in the swelling agent but which.
is substantially a nonsolvent for the methylcellulose, thereby substantially replacing with the liquid material the organic swelling agent present in the inner structure of the methylcellulose mass; adding water; and thereafter consecutively removing the swelling agent, liquid material, and water from the methylcellulose, thereby obtaining as a solid residue a fiufi'y, porous, methylcellulose product, the fibers and fibrils of which are maintained in a divided and opened condition.
8. A process of treating methylcellulose which comprises subjecting the methylcellulose to the action of an evaporatable, organic, liquid, swelling agent therefor, thereby dividing and opening up its fibers and fibrils; mixing'with the methylcellulose and swelling agent a liquid material which is soluble in the swelling agent but which is substantially a nonsolvent for the methylcellulose, thereby substantially replacing with the liquid material the organic swelling agent present in the inner structure of the methylcellulose mass; adding a surface active agent and while the fibers and fibrils of the methylcellulose are divided and opened; and thereafter consecutively removing the swelling agent and liquid material from the methylcellulose, thereby obtaining as a solid residue a flufiy, porous, methylcellulose product, the fibers and fibrils of which are maintained in a divided and opened condition. 7
9. A process of treating methylcellulose which comprises subjecting the methylcellulose to the action of an evaporatable, organic, liquid, swell ing agent therefor, thereby dividing and opening up its fibers and fibrils; mixing with the methyl- 21 cellulose and swelling agent a liquid material which is soluble in the swelling agent but which is substantially a nonsolvent for the methylcellulose, thereby substantially replacing with the liquid material the organic swelling agent present in the inner structure of the methylcellulose mass; adding a binder for the end product and while the fibers and fibrils of the methylcellulose are divided and opened; and thereafter consecutively removing the swelling agent and liquid material from the methyl cellulose, thereby obtaining as a solid residue a flufl'y, porous, methylcellulose product, the fibers and fibrils of which are maintained in a divided and opened condition.
10. A process of treating methylcellulose which comprises subjecting the methylcellulose to the action of an evaporatable, organic, liquid, swelling agent therefor, thereby dividing and opening up its fibers and fibrils; mixing with the 20 methylcellulose and swelling agent a liquid material having a boiling point about 15 C. to about 20 C. above that of the swelling agent and which is soluble in the swelling agent but which is substantially a nons'olvent for the methylcellulose, thereby substantially replacing with the liquid material the organic swellin 22 agent present in the inner structure of the methylcellulose mass; adding a medicament while the said methylcellulose is Present in at least said organicliquidand while the fibers and REFERENCES CITED The following references are of record in the file of this patent:
UNITED STATES PATENTS Number Name Date 85,188 Thompson Dec. 22, 1868 881,098 Diskin Mar. 3, 1908 2,107,005 Le Fevre et a1. Feb. 1, 1938 2,121,731 Collings June 21, 1938 2,163,588 Cornish June 2'7, 1939 2,176,678 Neuroth- Oct. 17, 1939 2,298,424 Schreiber Oct. 13, 1942

Claims (1)

  1. 6. A PROCESS OF TREATING METHYLCELLULOSE WHICH COMPRISES SUBJECTING THE METHYLCELLULOSE TO THE ACTION OF AN EVAPORATABLE, ORGANIC, LIQUID, SWELLING AGENT THEREFOR, THEREBY DIVIDING THE OPENING UP ITS FIBERS AND FIBRILS; MIXING WITH THE METHYLCELLULOSE AND SWELLING AGENT A LIQUID MATERIAL HAVING A BOILING POINT ABOUT 15* C. TO ABOUT 20* C. ABOVE THAT OF THE SWELLING AGENT AND WHICH IS SOLUBLE IN THE SWELLING AGENT BUT WHICH IS SUBSTANTIALLY A NONSOLVENT FOR THE METHYLCELLULOSE, THEREBY SUBSTANTIALLY REPLACING WITH THE LIQUID MATERIAL THE ORGANIC SWELLING AGENT PRESENT IN THE INNER STRUCTURE OF THE METHYLCELLULOSE MASS; ADDING A MEDICAMENT WHILE THE SAID METHYLCELLULOSE IS PRESENT IN AT LEAST SAID ORGANIC LIQUID AND WHILE THE FIBERS AND FIBRILS ARE DIVIDED AND OPENED; AND THEREAFTER CONSECUTIVELY REMOVING THE SWELLING AGENT THE LIQUID MATERIAL FROM THE METHYLCELLULOSE, THEREBY OBTAINING AS A SOLID RESIDUE A FLUFFY, POROUS, METHYLCELLULOSE PRODUCT, THE FIBERS AND FIBRILS OF WHICH ARE MAINTAINED IN A DIVIDED AND OPENED CONDITION AND CONTAINING A MEDICAMENT.
US769071A 1947-08-16 1947-08-16 Processing methyl cellulose and the products thereof Expired - Lifetime US2602042A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US769071A US2602042A (en) 1947-08-16 1947-08-16 Processing methyl cellulose and the products thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US769071A US2602042A (en) 1947-08-16 1947-08-16 Processing methyl cellulose and the products thereof

Publications (1)

Publication Number Publication Date
US2602042A true US2602042A (en) 1952-07-01

Family

ID=25084356

Family Applications (1)

Application Number Title Priority Date Filing Date
US769071A Expired - Lifetime US2602042A (en) 1947-08-16 1947-08-16 Processing methyl cellulose and the products thereof

Country Status (1)

Country Link
US (1) US2602042A (en)

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2779332A (en) * 1953-11-25 1957-01-29 Harry J Corper Procedure for intracorporal intra-and subcutaneous test, therapy, immunization, vaccination, and drug adminstration
US2849000A (en) * 1953-06-08 1958-08-26 Tampax Inc Tampons and the like
US2877115A (en) * 1957-04-16 1959-03-10 Vanity Fair Paper Mills Inc Fibrous material product containing lanolin and method for making same
US2918404A (en) * 1956-07-30 1959-12-22 Ortho Pharma Corp Solid compressed amino acid spermicidal vehicle
US2992971A (en) * 1956-11-29 1961-07-18 Ortho Pharma Corp Biological stains
US2996432A (en) * 1961-04-07 1961-08-15 Modern Lab Inc Skin treating composition and method
US3005457A (en) * 1957-04-01 1961-10-24 Ortho Pharma Corp Methyl cellulose sponge and method of making
US3038819A (en) * 1958-08-25 1962-06-12 Sidney H Ross Antibiotics as preservatives for industrial materials
US3108043A (en) * 1960-05-09 1963-10-22 Ortho Pharma Corp Spermicidal sheet-like material
US3194732A (en) * 1960-10-03 1965-07-13 Neuhauser Irene Assisting healing of skin-denuded areas on the body with dried non-fibrous egg-shellmembrane products and compositions therefor
US3196075A (en) * 1960-10-03 1965-07-20 Neuhauser Irene Assisting healing of skin-denuded areas on the human body with dried fibrous egg-shell membrane products and compositions therefor
US3328259A (en) * 1964-01-08 1967-06-27 Parachem Corp Dressing for a wound containing a hemostatic agent and method of treating a wound
US3395063A (en) * 1962-04-10 1968-07-30 Pires And Mourato Vermelho Process for the preparation of sterile dressings
US3431138A (en) * 1967-07-14 1969-03-04 American Cyanamid Co Method for coating pharmaceutical forms with methyl cellulose
US3707148A (en) * 1969-06-05 1972-12-26 Boots Pure Drug Co Ltd Impregnated diaper
EP0009977A1 (en) * 1978-10-05 1980-04-16 Unilever Plc A water-swellable particulate absorbent material and method for producing this material
US4225580A (en) * 1973-01-29 1980-09-30 Pharmacia Aktiebolag Method for cleansing fluid discharging skin surfaces, wounds and mucous membranes and means for carrying out the method
US4256877A (en) * 1976-12-21 1981-03-17 Sca Development Aktiebolag Method of manufacturing cellulose derivative
US4292972A (en) * 1980-07-09 1981-10-06 E. R. Squibb & Sons, Inc. Lyophilized hydrocolloio foam
US4534962A (en) * 1980-12-29 1985-08-13 Colgate-Palmolive Company Sodium bicarbonate suspension as deodorant product
US4537767A (en) * 1973-01-29 1985-08-27 Pharmacia Aktiebolag Method for cleansing fluid discharging skin surfaces, wounds and mucous membranes and means for carrying out the method
US4538603A (en) * 1982-04-22 1985-09-03 E. R. Squibb & Sons, Inc. Dressings, granules, and their use in treating wounds
US4626287A (en) * 1985-01-29 1986-12-02 Merrell Dow Pharmaceuticals Inc. Process for preparing sucrose encrusted methylcellulose particles for use in bulk laxative compositions
US4664909A (en) * 1980-12-29 1987-05-12 Colgate-Palmolive Company Stable suspension of powder in alcoholic media
US4830854A (en) * 1987-12-18 1989-05-16 James B. Copelan Chemical splinter removal
US5000950A (en) * 1982-07-14 1991-03-19 Smith & Nephew Medical Ltd. Agent for the treatment of wounds
US5024838A (en) * 1988-03-02 1991-06-18 Vicente Parrilla Compositions for the treatment of skin injuries
US6010444A (en) * 1997-09-05 2000-01-04 Isolyser Company, Inc. Infectious waste containment system
US20080076722A1 (en) * 2006-09-27 2008-03-27 Hemostasis, Llc Hemostatic Agent and Method
US20080082084A1 (en) * 2006-09-29 2008-04-03 Hemostasis, Llc System and Method to Vent Gas From a Body Cavity
US20090226391A1 (en) * 2008-03-04 2009-09-10 Hemostasis, Llc Hemostatic Sponge and Method of Manufacture
US20110052663A1 (en) * 2009-09-01 2011-03-03 Hemostasis, Llc Hemostatic Sponge with Enzyme and Method of Manufacture
US8585646B2 (en) 2008-03-03 2013-11-19 Lexion Medical, Llc System and method to vent gas from a body cavity

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US85188A (en) * 1868-12-22 George w
US881098A (en) * 1907-09-27 1908-03-03 Moses B Diskin Paper-board.
US2107005A (en) * 1937-02-05 1938-02-01 Dow Chemical Co Cellulose ether recovery
US2121731A (en) * 1936-07-30 1938-06-21 Dow Chemical Co Cellulose ether recovery
US2163588A (en) * 1935-11-23 1939-06-27 Robert E Cornish Hemorrhage arrester
US2176678A (en) * 1937-04-17 1939-10-17 Kalle & Co Ag Method of treating cellulose ethers
US2298424A (en) * 1940-05-07 1942-10-13 Johnson & Johnson Absorbent material

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US85188A (en) * 1868-12-22 George w
US881098A (en) * 1907-09-27 1908-03-03 Moses B Diskin Paper-board.
US2163588A (en) * 1935-11-23 1939-06-27 Robert E Cornish Hemorrhage arrester
US2121731A (en) * 1936-07-30 1938-06-21 Dow Chemical Co Cellulose ether recovery
US2107005A (en) * 1937-02-05 1938-02-01 Dow Chemical Co Cellulose ether recovery
US2176678A (en) * 1937-04-17 1939-10-17 Kalle & Co Ag Method of treating cellulose ethers
US2298424A (en) * 1940-05-07 1942-10-13 Johnson & Johnson Absorbent material

Cited By (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2849000A (en) * 1953-06-08 1958-08-26 Tampax Inc Tampons and the like
US2779332A (en) * 1953-11-25 1957-01-29 Harry J Corper Procedure for intracorporal intra-and subcutaneous test, therapy, immunization, vaccination, and drug adminstration
US2918404A (en) * 1956-07-30 1959-12-22 Ortho Pharma Corp Solid compressed amino acid spermicidal vehicle
US2992971A (en) * 1956-11-29 1961-07-18 Ortho Pharma Corp Biological stains
US3005457A (en) * 1957-04-01 1961-10-24 Ortho Pharma Corp Methyl cellulose sponge and method of making
US2877115A (en) * 1957-04-16 1959-03-10 Vanity Fair Paper Mills Inc Fibrous material product containing lanolin and method for making same
US3038819A (en) * 1958-08-25 1962-06-12 Sidney H Ross Antibiotics as preservatives for industrial materials
US3108043A (en) * 1960-05-09 1963-10-22 Ortho Pharma Corp Spermicidal sheet-like material
US3194732A (en) * 1960-10-03 1965-07-13 Neuhauser Irene Assisting healing of skin-denuded areas on the body with dried non-fibrous egg-shellmembrane products and compositions therefor
US3196075A (en) * 1960-10-03 1965-07-20 Neuhauser Irene Assisting healing of skin-denuded areas on the human body with dried fibrous egg-shell membrane products and compositions therefor
US2996432A (en) * 1961-04-07 1961-08-15 Modern Lab Inc Skin treating composition and method
US3395063A (en) * 1962-04-10 1968-07-30 Pires And Mourato Vermelho Process for the preparation of sterile dressings
US3328259A (en) * 1964-01-08 1967-06-27 Parachem Corp Dressing for a wound containing a hemostatic agent and method of treating a wound
US3431138A (en) * 1967-07-14 1969-03-04 American Cyanamid Co Method for coating pharmaceutical forms with methyl cellulose
US3707148A (en) * 1969-06-05 1972-12-26 Boots Pure Drug Co Ltd Impregnated diaper
US4537767A (en) * 1973-01-29 1985-08-27 Pharmacia Aktiebolag Method for cleansing fluid discharging skin surfaces, wounds and mucous membranes and means for carrying out the method
US4225580A (en) * 1973-01-29 1980-09-30 Pharmacia Aktiebolag Method for cleansing fluid discharging skin surfaces, wounds and mucous membranes and means for carrying out the method
US4256877A (en) * 1976-12-21 1981-03-17 Sca Development Aktiebolag Method of manufacturing cellulose derivative
EP0009977A1 (en) * 1978-10-05 1980-04-16 Unilever Plc A water-swellable particulate absorbent material and method for producing this material
US4292972A (en) * 1980-07-09 1981-10-06 E. R. Squibb & Sons, Inc. Lyophilized hydrocolloio foam
US4534962A (en) * 1980-12-29 1985-08-13 Colgate-Palmolive Company Sodium bicarbonate suspension as deodorant product
US4664909A (en) * 1980-12-29 1987-05-12 Colgate-Palmolive Company Stable suspension of powder in alcoholic media
US4538603A (en) * 1982-04-22 1985-09-03 E. R. Squibb & Sons, Inc. Dressings, granules, and their use in treating wounds
US5000950A (en) * 1982-07-14 1991-03-19 Smith & Nephew Medical Ltd. Agent for the treatment of wounds
US4626287A (en) * 1985-01-29 1986-12-02 Merrell Dow Pharmaceuticals Inc. Process for preparing sucrose encrusted methylcellulose particles for use in bulk laxative compositions
US4671823A (en) * 1985-01-29 1987-06-09 Merrell Dow Pharmaceuticals Inc. Sucrose encrusted methyl cellulose particles for use in bulk laxative compositions
US4732917A (en) * 1985-01-29 1988-03-22 Merrell Dow Pharmaceuticals Inc. Process for preparing sucrose encrusted methylcellulose particles for use in bulk laxative compositions
US4830854A (en) * 1987-12-18 1989-05-16 James B. Copelan Chemical splinter removal
US5024838A (en) * 1988-03-02 1991-06-18 Vicente Parrilla Compositions for the treatment of skin injuries
US6010444A (en) * 1997-09-05 2000-01-04 Isolyser Company, Inc. Infectious waste containment system
US9649482B2 (en) 2006-09-27 2017-05-16 Hemostasis, Llc Hemostatic agent and method
US20080076722A1 (en) * 2006-09-27 2008-03-27 Hemostasis, Llc Hemostatic Agent and Method
US10744310B2 (en) 2006-09-27 2020-08-18 Hemostasis, Llc Hemostatic agent and method
US8623842B2 (en) 2006-09-27 2014-01-07 Hemostasis, Llc Hemostatic agent and method
US20080082084A1 (en) * 2006-09-29 2008-04-03 Hemostasis, Llc System and Method to Vent Gas From a Body Cavity
US8414550B2 (en) 2006-09-29 2013-04-09 Lexion Medical, Llc System and method to vent gas from a body cavity
US8608715B2 (en) 2006-09-29 2013-12-17 Lexion Medical, Llc System and method to vent gas from a body cavity
US8585646B2 (en) 2008-03-03 2013-11-19 Lexion Medical, Llc System and method to vent gas from a body cavity
US9821095B2 (en) 2008-03-03 2017-11-21 Lexion Medical, Llc System and method to vent gas from a body cavity
US20090226391A1 (en) * 2008-03-04 2009-09-10 Hemostasis, Llc Hemostatic Sponge and Method of Manufacture
US9061087B2 (en) 2008-03-04 2015-06-23 Hemostasis, Llc Method of making a hemostatic sponge wound dressing comprising subjecting the sponge to water vapor
US20110052663A1 (en) * 2009-09-01 2011-03-03 Hemostasis, Llc Hemostatic Sponge with Enzyme and Method of Manufacture

Similar Documents

Publication Publication Date Title
US2602042A (en) Processing methyl cellulose and the products thereof
US3287222A (en) Method for preparation of synthetic fiber medical dressing impregnated with therapeutic
DE69206407T3 (en) WOUND DRESSING.
US2558395A (en) Undenatured gelatin hemostatic sponge containing thrombin
US4393048A (en) Protective gel composition for wounds
CA1049407A (en) Method for treating fluid-discharging skin surfaces, wounds, sores and mucous membranes and means for carrying out the method
US2688586A (en) Improved hemostatic alginic surgical dressings and method of making
US4190563A (en) Particulate absorbant material surface treated with polyether to improve dispersibility in blood
AU716244B2 (en) Sterilisable paste product for topical application
EP0009977B1 (en) A water-swellable particulate absorbent material and method for producing this material
US3393080A (en) Microcrystalline colloidal collagen dispersions in dispersing media containing dimethyl sulfoxide and water-miscible organic solvents
US4024223A (en) Stripe composition and method of reducing smell associated therewith
US4296234A (en) Absorbent materials
DE60203264T2 (en) Microbial cellulose wound dressing for the treatment of chronic wounds
US2484637A (en) Powdered ointment base of methyl cellulose and sorbitol
CA1116517A (en) Transparent liquid dressing material
US5441741A (en) Freeze-dried pad
DE3606265A1 (en) POLYSACCHARID-BASED Wound Dressing As a Carrier Therapeutically Effective, Non-Immobilized Enzymes and with High Absorbency
JP2021107606A (en) Chitin-modified pp spun-bonded nonwoven fabric, and production method of the same
JP6716841B2 (en) Hemostatic material
US4778786A (en) Composition for transdermal drug delivery
DE2356098C3 (en) Composition for envelopes
US3300387A (en) Pressed powder antiperspirant and method of preparation
US3238100A (en) Starch phosphate film composition and method of dressing wounds with same
WO2019026177A1 (en) Hemostatic material and wound dressing material containing same